Jim Simons’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.28M | Buy |
637,174
+216,000
| +51% | +$858K | ﹤0.01% | 1834 |
|
|
2025
Q4 | $1.48M | Buy |
421,174
+283,997
| +207% | +$972K | ﹤0.01% | 2055 |
|
|
2025
Q3 | $447K | Sell |
137,177
-324,197
| -70% | -$1.02M | ﹤0.01% | 2846 |
|
|
2025
Q2 | $1.13M | Buy |
461,374
+122,900
| +36% | +$623K | ﹤0.01% | 2449 |
|
|
2025
Q1 | $2.26M | Buy |
338,474
+119,955
| +55% | +$1.19M | ﹤0.01% | 1924 |
|
|
2024
Q4 | $2.75M | Buy |
+218,519
| New | +$3.29M | ﹤0.01% | 1839 |
|
|
2024
Q3 | – | Sell |
-99,574
| Closed | -$2.14M | – | 3815 |
|
|
2024
Q2 | $2.14M | Buy |
+99,574
| New | +$2.29M | ﹤0.01% | 1844 |
|
|
2024
Q1 | – | Sell |
-62,674
| Closed | -$1.88M | – | 4003 |
|
|
2023
Q4 | $1.88M | Sell |
62,674
-130,800
| -68% | -$2.89M | ﹤0.01% | 1988 |
|
|
2023
Q3 | $3.96M | Buy |
193,474
+164,600
| +570% | +$2.99M | 0.01% | 1433 |
|
|
2023
Q2 | $574K | Sell |
28,874
-84,500
| -75% | -$1.71M | ﹤0.01% | 2800 |
|
|
2023
Q1 | $1.94M | Sell |
113,374
-45,426
| -29% | -$889K | ﹤0.01% | 2049 |
|
|
2022
Q4 | $3.11M | Sell |
158,800
-321,000
| -67% | -$5.91M | ﹤0.01% | 1793 |
|
|
2022
Q3 | $7.66M | Buy |
479,800
+45,900
| +11% | +$716K | 0.01% | 1171 |
|
|
2022
Q2 | $5.97M | Buy |
433,900
+277,400
| +177% | +$3.31M | 0.01% | 1432 |
|
|
2022
Q1 | $2.48M | Buy |
156,500
+4,701
| +3% | +$81.2K | ﹤0.01% | 2068 |
|
|
2021
Q4 | $3.31M | Buy |
151,799
+36,306
| +31% | +$990K | ﹤0.01% | 1793 |
|
|
2021
Q3 | $3.45M | Buy |
115,493
+95,393
| +475% | +$3.47M | ﹤0.01% | 1690 |
|
|
2021
Q2 | $890K | Sell |
20,100
-35,490
| -64% | -$1.54M | ﹤0.01% | 2724 |
|
|
2021
Q1 | $2.47M | Buy |
+55,590
| New | +$3.05M | ﹤0.01% | 2086 |
|
|
2020
Q2 | – | Sell |
-93,600
| Closed | -$1.31M | – | 3707 |
|
|
2020
Q1 | $1.31M | Buy |
+93,600
| New | +$1.85M | ﹤0.01% | 2288 |
|
|
2019
Q4 | – | Sell |
-27,900
| Closed | -$325K | – | 3702 |
|
|
2019
Q3 | $325K | Buy |
+27,900
| New | +$346K | ﹤0.01% | 3013 |
|
|
2019
Q2 | – | Sell |
-17,301
| Closed | -$303K | – | 3720 |
|
|
2019
Q1 | $303K | Sell |
17,301
-18,517
| -52% | -$292K | ﹤0.01% | 3091 |
|
|
2018
Q4 | $531K | Sell |
35,818
-31,007
| -46% | -$515K | ﹤0.01% | 2847 |
|
|
2018
Q3 | $1.65M | Sell |
66,825
-196,820
| -75% | -$4.27M | ﹤0.01% | 2376 |
|
|
2018
Q2 | $5.17M | Buy |
263,645
+95,970
| +57% | +$1.82M | 0.01% | 1771 |
|
|
2018
Q1 | $3.14M | Buy |
+167,675
| New | +$2.73M | ﹤0.01% | 2081 |
|
Other funds holding RCKT
RI
VPM
VCM
MC
NM
N
Jim Simons's RCKT Position: Q1 2026 in Review
Jim Simons increased its Rocket Pharmaceuticals (RCKT) stake by 51% in Q1 2026, buying an estimated $858K and bringing the position to 637,174 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1834.
Jim Simons first reported a position in RCKT in Q1 2018 and has held it in 26 quarters since. The position peaked at $7.66M in Q3 2022. 199 funds tracked by Wall St. Rank hold RCKT as of Q1 2026.
- Jim Simons held 637,174 shares of Rocket Pharmaceuticals worth $2.28M as of Q1 2026.
- Jim Simons bought 216,000 Rocket Pharmaceuticals shares in Q1 2026, an estimated $858K.
- Rocket Pharmaceuticals made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1834 holding.
- Jim Simons first reported a position in Rocket Pharmaceuticals in Q1 2018 and has held it in 26 quarters since.
- Jim Simons's Rocket Pharmaceuticals position peaked at $7.66M in Q3 2022.
- 199 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.